Sumitomo Pharma Company Limited is a Japanese multinational pharmaceutical company. The company is focused on oncology, psychiatry, neurology, women's health issues, urological diseases among other areas. Its headquarters are located in Chuo-ku, Osaka. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Sumitomo Dainippon Pharma (Japan), Japan, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
45%
Total
Publications
1.9K
Total Open
Publications
871
Total
Citations
56K
Open Access
Percentage
45%
Total
Publications
1.9K
Total Open
Publications
871
Total
Citations
56K
Breakdown
Publisher Open
23%
Both
17%
Other Platform Open
5%
Closed
55%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 26%
202
Hybrid 28%
215
No Guarantees 46%
354
Other Platform Open
Domain 84%
362
Institution 16%
71
Public 9%
39
Preprint 8%
33
Other Internet 8%
33
Other Platform Locations
Name | Platform Type | Publications |
---|---|---|
PubMed Central | Domain | 361 |
Europe PMC | Domain | 168 |
Semantic Scholar | Public | 35 |
DOI | Other Internet | 28 |
Research Square | Preprint | 16 |
Kyoto University - Kyoto University Research Information Repository | Institution | 15 |
Kobe University - Kobe University Repository Kernel | Institution | 13 |
bioRxiv | Preprint | 11 |
Hokkaido University - Hokkaido University Collection of Scholarly and Academic Papers | Institution | 9 |
University of California - eScholarship University of California | Institution | 8 |